BioCentury
ARTICLE | Emerging Company Profile

New shot at sepsis

How Critical Pressure’s CPL001 could stabilize septic shock patients

November 17, 2017 10:18 PM UTC

Critical Pressure Ltd. is developing a therapy for septic shock to combat hypotension more effectively than marketed vasopressors, and without their side effects.

Sepsis is a systemic inflammatory response triggered by severe bacterial infection. Over 30% of patients with sepsis develop septic shock, which is characterized by severe hypotension that can lead to tissue damage, multiple organ failure and death. ...